DRUG STUDY

Date Generic Brand Classificat Indication Mechanism Dosage & Time Adverse Nursing
Name Name ion of Action Frequency Given Reaction Consideration
05-08- Quetiapine Seroquel Therapeut Schizophr Probably BIPOLAR CNS: · Monitor
21 ic: enia. acts by MANIA NEUROLE and
antipsych Depressiv serving as TREATME PTIC immediately
otics, e an NT: MALIGNAN report signs of
mood episodes antagonist IR T neuroleptic
stabilizerswith of Tablets: SYNDROM malignant
bipolar dopamine -Day 1: 50 E, syndrome,
Pharmaco disorder. and mg orally SEIZURES including
logic: Acute serotonin. 2 times a , dizziness, hyperthermia,
dibenzothi manic Also day cognitive diaphoresis,
azeprine episodes antagonize -Day 2: impairment, generalized
derivative associate s histamine 100 mg extrapyrami muscle rigidity,
s d with H1 orally 2 dal decreased
bipolar I receptors times a symptoms, cognition,
disorder and alpha1- day sedation, tachycardia,
(as adrenergic -Day 3: tardive changes in
monother receptors. 150 mg dyskinesia. blood pressure
apy or Therapeuti orally 2 EENT: ear (BP), and
with c Effects: times a pain, incontinence.
lithium or Decreased day rhinitis, Symptoms
divalproex manifestati -Day 4: pharyngitis. typically occur
). ons of 200 mg Resp: within 4–14
Maintena psychoses, orally 2 cough, days after
nce depression, times a dyspnea. initiation of
treatment or acute day CV: drug therapy,
of bipolar mania. -Titration palpitations but can occur at
I disorder regimen: , peripheral any time during
(with Further edema, drug use.
lithium or dose orthostatic
divalproex adjustmen hypotensio · Be alert for
). ts should n. GI: new seizures or
be in anorexia, increased
increment constipatio seizure activity,
s of no n, dry especially at
greater mouth, the onset of
than 200 dyspepsia. drug treatment.
mg/day Derm: Document the
- sweating. number,
Maintenan Hemat: duration, and
ce dose: leukopenia. severity of
400 to 800 Metab: seizures, and
mg per weight report these